Report Detail
Global Basal Cell Carcinoma Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030
- RnM2766296 |
- 26 September, 2024 |
- Global |
- 72 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
Basal cell carcinoma (BCC) is the most common type of skin cancer. It’s also the most commonly diagnosed cancer in the United States. Every year, millions of people learn that they have BCC.
Basal cell carcinoma that is superficial and doesn"t extend very far into the skin may be treated with creams or ointments. Surgical options are Electrodesiccation and curettage (ED&C), Topical Treatment, Freezing and Mohs Surgery. Drugs options, imiquimod (Aldara) and fluorouracil (Efudex, Fluoroplex, others) are used for several weeks to treat such low-risk basal cell carcinomas. Basal cell carcinoma that spreads to other areas of the body (metastasizes) may be treated with vismodegib (Erivedge) or sonidegib (Odomzo).
According to our (Global Info Research) latest study, the global Basal Cell Carcinoma Treatment market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
The classification of Basal Cell Carcinoma Treatment includes Topical Treatment, Hedgehog Pathway Inhibitor Therapy, Mohs Surgery, Other Surgeries and Other Treatments, and the proportion of Topical Treatment in 2018 is about 30.4%. Basal Cell Carcinoma Treatment is widely used in Hospitals, Specialty Clinics and other field. The most proportion of Basal Cell Carcinoma Treatment is Hospitals, and the sales proportion in 2018 is 53.2%. Market competition is intense. Roche, Sun Pharmaceuticals, Bausch Health Companies, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
This report is a detailed and comprehensive analysis for global Basal Cell Carcinoma Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Basal Cell Carcinoma Treatment market size and forecasts, in consumption value ($ Million), 2019-2030
Global Basal Cell Carcinoma Treatment market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Basal Cell Carcinoma Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Basal Cell Carcinoma Treatment market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Basal Cell Carcinoma Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Basal Cell Carcinoma Treatment market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Sun Pharmaceuticals, Bausch Health Companies, Taro Pharmaceuticals, Mylan, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Basal Cell Carcinoma Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Basal Cell Carcinoma Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Topical Treatment
Hedgehog Pathway Inhibitor Therapy
Mohs Surgery
Other Surgeries
Other Treatments
Market segment by Application
Hospitals
Specialty Clinics
Others
Market segment by players, this report covers
Roche
Sun Pharmaceuticals
Bausch Health Companies
Taro Pharmaceuticals
Mylan
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Basal Cell Carcinoma Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Basal Cell Carcinoma Treatment, with revenue, gross margin, and global market share of Basal Cell Carcinoma Treatment from 2019 to 2024.
Chapter 3, the Basal Cell Carcinoma Treatment competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Basal Cell Carcinoma Treatment market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Basal Cell Carcinoma Treatment.
Chapter 13, to describe Basal Cell Carcinoma Treatment research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Basal Cell Carcinoma Treatment by Type
- 1.3.1 Overview: Global Basal Cell Carcinoma Treatment Market Size by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Global Basal Cell Carcinoma Treatment Consumption Value Market Share by Type in 2023
- 1.3.3 Topical Treatment
- 1.3.4 Hedgehog Pathway Inhibitor Therapy
- 1.3.5 Mohs Surgery
- 1.3.6 Other Surgeries
- 1.3.7 Other Treatments
- 1.4 Global Basal Cell Carcinoma Treatment Market by Application
- 1.4.1 Overview: Global Basal Cell Carcinoma Treatment Market Size by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Hospitals
- 1.4.3 Specialty Clinics
- 1.4.4 Others
- 1.5 Global Basal Cell Carcinoma Treatment Market Size & Forecast
- 1.6 Global Basal Cell Carcinoma Treatment Market Size and Forecast by Region
- 1.6.1 Global Basal Cell Carcinoma Treatment Market Size by Region: 2019 VS 2023 VS 2030
- 1.6.2 Global Basal Cell Carcinoma Treatment Market Size by Region, (2019-2030)
- 1.6.3 North America Basal Cell Carcinoma Treatment Market Size and Prospect (2019-2030)
- 1.6.4 Europe Basal Cell Carcinoma Treatment Market Size and Prospect (2019-2030)
- 1.6.5 Asia-Pacific Basal Cell Carcinoma Treatment Market Size and Prospect (2019-2030)
- 1.6.6 South America Basal Cell Carcinoma Treatment Market Size and Prospect (2019-2030)
- 1.6.7 Middle East & Africa Basal Cell Carcinoma Treatment Market Size and Prospect (2019-2030)
2 Company Profiles
- 2.1 Roche
- 2.1.1 Roche Details
- 2.1.2 Roche Major Business
- 2.1.3 Roche Basal Cell Carcinoma Treatment Product and Solutions
- 2.1.4 Roche Basal Cell Carcinoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Roche Recent Developments and Future Plans
- 2.2 Sun Pharmaceuticals
- 2.2.1 Sun Pharmaceuticals Details
- 2.2.2 Sun Pharmaceuticals Major Business
- 2.2.3 Sun Pharmaceuticals Basal Cell Carcinoma Treatment Product and Solutions
- 2.2.4 Sun Pharmaceuticals Basal Cell Carcinoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Sun Pharmaceuticals Recent Developments and Future Plans
- 2.3 Bausch Health Companies
- 2.3.1 Bausch Health Companies Details
- 2.3.2 Bausch Health Companies Major Business
- 2.3.3 Bausch Health Companies Basal Cell Carcinoma Treatment Product and Solutions
- 2.3.4 Bausch Health Companies Basal Cell Carcinoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Bausch Health Companies Recent Developments and Future Plans
- 2.4 Taro Pharmaceuticals
- 2.4.1 Taro Pharmaceuticals Details
- 2.4.2 Taro Pharmaceuticals Major Business
- 2.4.3 Taro Pharmaceuticals Basal Cell Carcinoma Treatment Product and Solutions
- 2.4.4 Taro Pharmaceuticals Basal Cell Carcinoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 Taro Pharmaceuticals Recent Developments and Future Plans
- 2.5 Mylan
- 2.5.1 Mylan Details
- 2.5.2 Mylan Major Business
- 2.5.3 Mylan Basal Cell Carcinoma Treatment Product and Solutions
- 2.5.4 Mylan Basal Cell Carcinoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Mylan Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Basal Cell Carcinoma Treatment Revenue and Share by Players (2019-2024)
- 3.2 Market Share Analysis (2023)
- 3.2.1 Market Share of Basal Cell Carcinoma Treatment by Company Revenue
- 3.2.2 Top 3 Basal Cell Carcinoma Treatment Players Market Share in 2023
- 3.2.3 Top 6 Basal Cell Carcinoma Treatment Players Market Share in 2023
- 3.3 Basal Cell Carcinoma Treatment Market: Overall Company Footprint Analysis
- 3.3.1 Basal Cell Carcinoma Treatment Market: Region Footprint
- 3.3.2 Basal Cell Carcinoma Treatment Market: Company Product Type Footprint
- 3.3.3 Basal Cell Carcinoma Treatment Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Basal Cell Carcinoma Treatment Consumption Value and Market Share by Type (2019-2024)
- 4.2 Global Basal Cell Carcinoma Treatment Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
- 5.1 Global Basal Cell Carcinoma Treatment Consumption Value Market Share by Application (2019-2024)
- 5.2 Global Basal Cell Carcinoma Treatment Market Forecast by Application (2025-2030)
6 North America
- 6.1 North America Basal Cell Carcinoma Treatment Consumption Value by Type (2019-2030)
- 6.2 North America Basal Cell Carcinoma Treatment Market Size by Application (2019-2030)
- 6.3 North America Basal Cell Carcinoma Treatment Market Size by Country
- 6.3.1 North America Basal Cell Carcinoma Treatment Consumption Value by Country (2019-2030)
- 6.3.2 United States Basal Cell Carcinoma Treatment Market Size and Forecast (2019-2030)
- 6.3.3 Canada Basal Cell Carcinoma Treatment Market Size and Forecast (2019-2030)
- 6.3.4 Mexico Basal Cell Carcinoma Treatment Market Size and Forecast (2019-2030)
7 Europe
- 7.1 Europe Basal Cell Carcinoma Treatment Consumption Value by Type (2019-2030)
- 7.2 Europe Basal Cell Carcinoma Treatment Consumption Value by Application (2019-2030)
- 7.3 Europe Basal Cell Carcinoma Treatment Market Size by Country
- 7.3.1 Europe Basal Cell Carcinoma Treatment Consumption Value by Country (2019-2030)
- 7.3.2 Germany Basal Cell Carcinoma Treatment Market Size and Forecast (2019-2030)
- 7.3.3 France Basal Cell Carcinoma Treatment Market Size and Forecast (2019-2030)
- 7.3.4 United Kingdom Basal Cell Carcinoma Treatment Market Size and Forecast (2019-2030)
- 7.3.5 Russia Basal Cell Carcinoma Treatment Market Size and Forecast (2019-2030)
- 7.3.6 Italy Basal Cell Carcinoma Treatment Market Size and Forecast (2019-2030)
8 Asia-Pacific
- 8.1 Asia-Pacific Basal Cell Carcinoma Treatment Consumption Value by Type (2019-2030)
- 8.2 Asia-Pacific Basal Cell Carcinoma Treatment Consumption Value by Application (2019-2030)
- 8.3 Asia-Pacific Basal Cell Carcinoma Treatment Market Size by Region
- 8.3.1 Asia-Pacific Basal Cell Carcinoma Treatment Consumption Value by Region (2019-2030)
- 8.3.2 China Basal Cell Carcinoma Treatment Market Size and Forecast (2019-2030)
- 8.3.3 Japan Basal Cell Carcinoma Treatment Market Size and Forecast (2019-2030)
- 8.3.4 South Korea Basal Cell Carcinoma Treatment Market Size and Forecast (2019-2030)
- 8.3.5 India Basal Cell Carcinoma Treatment Market Size and Forecast (2019-2030)
- 8.3.6 Southeast Asia Basal Cell Carcinoma Treatment Market Size and Forecast (2019-2030)
- 8.3.7 Australia Basal Cell Carcinoma Treatment Market Size and Forecast (2019-2030)
9 South America
- 9.1 South America Basal Cell Carcinoma Treatment Consumption Value by Type (2019-2030)
- 9.2 South America Basal Cell Carcinoma Treatment Consumption Value by Application (2019-2030)
- 9.3 South America Basal Cell Carcinoma Treatment Market Size by Country
- 9.3.1 South America Basal Cell Carcinoma Treatment Consumption Value by Country (2019-2030)
- 9.3.2 Brazil Basal Cell Carcinoma Treatment Market Size and Forecast (2019-2030)
- 9.3.3 Argentina Basal Cell Carcinoma Treatment Market Size and Forecast (2019-2030)
10 Middle East & Africa
- 10.1 Middle East & Africa Basal Cell Carcinoma Treatment Consumption Value by Type (2019-2030)
- 10.2 Middle East & Africa Basal Cell Carcinoma Treatment Consumption Value by Application (2019-2030)
- 10.3 Middle East & Africa Basal Cell Carcinoma Treatment Market Size by Country
- 10.3.1 Middle East & Africa Basal Cell Carcinoma Treatment Consumption Value by Country (2019-2030)
- 10.3.2 Turkey Basal Cell Carcinoma Treatment Market Size and Forecast (2019-2030)
- 10.3.3 Saudi Arabia Basal Cell Carcinoma Treatment Market Size and Forecast (2019-2030)
- 10.3.4 UAE Basal Cell Carcinoma Treatment Market Size and Forecast (2019-2030)
11 Market Dynamics
- 11.1 Basal Cell Carcinoma Treatment Market Drivers
- 11.2 Basal Cell Carcinoma Treatment Market Restraints
- 11.3 Basal Cell Carcinoma Treatment Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Basal Cell Carcinoma Treatment Industry Chain
- 12.2 Basal Cell Carcinoma Treatment Upstream Analysis
- 12.3 Basal Cell Carcinoma Treatment Midstream Analysis
- 12.4 Basal Cell Carcinoma Treatment Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Basal Cell Carcinoma Treatment . Industry analysis & Market Report on Basal Cell Carcinoma Treatment is a syndicated market report, published as Global Basal Cell Carcinoma Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Basal Cell Carcinoma Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
